BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 24268684)

  • 1. The association between baseline clinical-radiological characteristics and growth of pulmonary nodules with ground-glass opacity.
    Kobayashi Y; Sakao Y; Deshpande GA; Fukui T; Mizuno T; Kuroda H; Sakakura N; Usami N; Yatabe Y; Mitsudomi T
    Lung Cancer; 2014 Jan; 83(1):61-6. PubMed ID: 24268684
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Natural history and clinical characteristics of multiple pulmonary nodules with ground glass opacity.
    Sato Y; Fujimoto D; Morimoto T; Uehara K; Nagata K; Sakanoue I; Hamakawa H; Takahashi Y; Imai Y; Tomii K
    Respirology; 2017 Nov; 22(8):1615-1621. PubMed ID: 28608997
    [TBL] [Abstract][Full Text] [Related]  

  • 3. How should we manage small focal pure ground-glass opacity nodules on high-resolution computed tomography? A single institute experience.
    Yamaguchi M; Furuya A; Edagawa M; Taguchi K; Shimamatsu S; Toyokawa G; Toyozawa R; Nosaki K; Hirai F; Seto T; Takenoyama M; Ichinose Y
    Surg Oncol; 2015 Sep; 24(3):258-63. PubMed ID: 26298200
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical, pathological and thin-section CT features of persistent multiple ground-glass opacity nodules: comparison with solitary ground-glass opacity nodule.
    Kim TJ; Goo JM; Lee KW; Park CM; Lee HJ
    Lung Cancer; 2009 May; 64(2):171-8. PubMed ID: 18799230
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pulmonary ground-glass opacity (GGO) lesions-large size and a history of lung cancer are risk factors for growth.
    Hiramatsu M; Inagaki T; Inagaki T; Matsui Y; Satoh Y; Okumura S; Ishikawa Y; Miyaoka E; Nakagawa K
    J Thorac Oncol; 2008 Nov; 3(11):1245-50. PubMed ID: 18978558
    [TBL] [Abstract][Full Text] [Related]  

  • 6. How long should small lung lesions of ground-glass opacity be followed?
    Kobayashi Y; Fukui T; Ito S; Usami N; Hatooka S; Yatabe Y; Mitsudomi T
    J Thorac Oncol; 2013 Mar; 8(3):309-14. PubMed ID: 23399958
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Predictive value of one-dimensional mean computed tomography value of ground-glass opacity on high-resolution images for the possibility of future change.
    Tamura M; Shimizu Y; Yamamoto T; Yoshikawa J; Hashizume Y
    J Thorac Oncol; 2014 Apr; 9(4):469-72. PubMed ID: 24736068
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Management of multiple pure ground-glass opacity lesions in patients with bronchioloalveolar carcinoma.
    Kim HK; Choi YS; Kim J; Shim YM; Lee KS; Kim K
    J Thorac Oncol; 2010 Feb; 5(2):206-10. PubMed ID: 19901852
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Natural history of pure ground-glass opacity lung nodules detected by low-dose CT scan.
    Chang B; Hwang JH; Choi YH; Chung MP; Kim H; Kwon OJ; Lee HY; Lee KS; Shim YM; Han J; Um SW
    Chest; 2013 Jan; 143(1):172-178. PubMed ID: 22797081
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tumor blood vessel in 3D reconstruction CT imaging as an risk indicator for growth of pulmonary nodule with ground-glass opacity.
    Xue W; Kong L; Zhang X; Xin Z; Zhao Q; He J; Wu W; Duan G
    J Cardiothorac Surg; 2023 Nov; 18(1):333. PubMed ID: 37968739
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Proportion and characteristics of transient nodules in a retrospective analysis of pulmonary nodules.
    Yu JY; Lee B; Ju S; Kim EY; Kim YH; Chi SY; Ban HJ; Kwon YS; Oh IJ; Kim KS; Kim YI; Lim SC; Choi S; Kim YH; Kim YC
    Thorac Cancer; 2012 Aug; 3(3):224-228. PubMed ID: 28920303
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Surgery for undiagnosed ground glass pulmonary nodules: decision making using serial computed tomography.
    Ueda K; Hayashi M; Tanaka N; Hoshii Y; Tanaka T; Hamano K
    World J Surg; 2015 Jun; 39(6):1452-9. PubMed ID: 25651958
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Management of ground-glass opacities: should all pulmonary lesions with ground-glass opacity be surgically resected?
    Kobayashi Y; Mitsudomi T
    Transl Lung Cancer Res; 2013 Oct; 2(5):354-63. PubMed ID: 25806254
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Survival of a surgical series of lung cancer patients with synchronous multiple ground-glass opacities, and the management of their residual lesions.
    Shimada Y; Saji H; Otani K; Maehara S; Maeda J; Yoshida K; Kato Y; Hagiwara M; Kakihana M; Kajiwara N; Ohira T; Akata S; Ikeda N
    Lung Cancer; 2015 May; 88(2):174-80. PubMed ID: 25758554
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Approach to the ground-glass nodule.
    Detterbeck FC; Homer RJ
    Clin Chest Med; 2011 Dec; 32(4):799-810. PubMed ID: 22054887
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Survival and risk factors for progression after resection of the dominant tumor in multifocal, lepidic-type pulmonary adenocarcinoma.
    Gao RW; Berry MF; Kunder CA; Khuong AA; Wakelee H; Neal JW; Backhus LM; Shrager JB
    J Thorac Cardiovasc Surg; 2017 Dec; 154(6):2092-2099.e2. PubMed ID: 28863952
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Ground-glass opacity and mixed pulmonary nodules: a new computed tomography semiology of the pulmonary adenocarcinoma].
    Couvreur T; Kerzmann A; Radermecker MA; Hermans G; Ghaye B
    Rev Med Liege; 2007; 62(7-8):515-22. PubMed ID: 17853676
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The long-term course of ground-glass opacities detected on thin-section computed tomography.
    Lee SW; Leem CS; Kim TJ; Lee KW; Chung JH; Jheon S; Lee JH; Lee CT
    Respir Med; 2013 Jun; 107(6):904-10. PubMed ID: 23514949
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Establishment and Verification of A Novel Predictive Model of Malignancy
for Non-solid Pulmonary Nodules].
    Xiao F; Yu Q; Zhang Z; Liu D; Liang C
    Zhongguo Fei Ai Za Zhi; 2019 Jan; 22(1):26-33. PubMed ID: 30674390
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ground-Glass Opacity Lung Nodules in the Era of Lung Cancer CT Screening: Radiology, Pathology, and Clinical Management.
    Pedersen JH; Saghir Z; Wille MM; Thomsen LH; Skov BG; Ashraf H
    Oncology (Williston Park); 2016 Mar; 30(3):266-74. PubMed ID: 26984222
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.